Skip to content

A Modified Constraint-Induced Movement Therapy Program in Rehabilitation of Arm Paresis in Children With Cerebral Palsy

Phase1 Effectiveness of a Modified Constraint-Induced Movement Therapy Program in Rehabilitation of Arm Paresis in Children With Cerebral Palsy: a Cross-Over Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00473447
Acronym
mCIT
Enrollment
10
Registered
2007-05-15
Start date
2004-01-31
Completion date
2006-04-30
Last updated
2007-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Hemiparesis

Keywords

Rehabilitation, Children, Cerebral Palsy, Arm, Paresis

Brief summary

The purpose of this study is to determine if a modified protocol of constraint-induced movement therapy (CIT) is effective in rehabilitation treatment of arm paresis in children with cerebral palsy. In these children one main problem the non-use of the affected arm. Many studies showed that the non-use phenomenon can by reversed by the CIT, a rehabilitation program consisting of 15 days of restraining the unaffected arm plus a daily intensive (6 hours/day) physiotherapy training of the paretic arm. The present study aims at evaluating if a shortened CIT protocol (restraining device plus only 2 weekly hours of physiotherapy) is effective in improving use and function of children paretic arm

Interventions

Sponsors

Universita di Verona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
1 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* presence of mild-moderate arm paresis (after cerebral palsy) enabling to * reach and grasp a pellet * age between 1-10 years * active participation during proposed activities * parents consent for participation -

Exclusion criteria

* presence of severe behaviour disturbances * presence of severe mental retardation (QI\<60)

Design outcomes

Primary

MeasureTime frame
Arm Use TestFour months for each patient

Secondary

MeasureTime frame
Arm Function TestFour months for each patient

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026